Gerard Cassidy, RBC Capital Markets analyst, joins 'Squawk on the Street' to discuss the latest bank earnings results.
RBC Capital analyst Ben Hendrix maintained a Hold rating on Walgreens Boots Alliance (WBA – Research Report) yesterday and set a price target ...
RBC Capital analyst Luca Issi reiterated a Buy rating on Ionis Pharmaceuticals (IONS – Research Report) today and set a price target of $70.00.
RBC Capital Markets raised its recommendation on KB Home (NYSE:KBH) and Lennar (NYSE:LEN), considering the homebuilders' ...
RBC Capital Markets analyst Pammi Bir published a look ahead to 2025 for REITs and emphasized four top picks, ...
Investing.com -- RBC Capital Markets has downgraded both Anglo American (JO: AGLJ) plc and Antofagasta (LON: ANTO) plc to ...
Vertex secures FDA approval for ALYFTREK and expands TRIKAFTA use, advances diabetes and kidney disease therapies, and ...
RBC Capital lowered the firm’s price target on Ovintiv (OVV) to $53 from $55 and keeps a Sector Perform rating on the shares. The firm’s assumed multiples reflect the company’s strong execution ...
The state of Colorado is moving forward with its plans to purchase Estes Park landmark The Stanley Hotel and fund a ...
BMO Capital Markets forecasts the S&P 500 will reach 6,700, reflecting a gain of 13.2%. Chief investment strategist Brian ...
The Los Angeles wildfires, which have reduced entire neighborhoods to smoldering ruins and left an apocalyptic landscape, ...
Investors in fertilizer equities can expect steady prices and good cash generation, according to analysts at RBC Capital ...